nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—HTR2C—metabolic syndrome X	0.719	1	CbGaD
Cabergoline—HTR7—sympathetic nervous system—metabolic syndrome X	0.00878	0.101	CbGeAlD
Cabergoline—HTR2A—arteriole—metabolic syndrome X	0.0086	0.0989	CbGeAlD
Cabergoline—HTR7—autonomic nervous system—metabolic syndrome X	0.0059	0.068	CbGeAlD
Cabergoline—HTR2A—sympathetic nervous system—metabolic syndrome X	0.00548	0.063	CbGeAlD
Cabergoline—HTR1B—artery—metabolic syndrome X	0.00434	0.05	CbGeAlD
Cabergoline—HTR1D—artery—metabolic syndrome X	0.0042	0.0484	CbGeAlD
Cabergoline—HTR2A—autonomic nervous system—metabolic syndrome X	0.00368	0.0424	CbGeAlD
Cabergoline—Toothache—Metformin—metabolic syndrome X	0.00363	0.0788	CcSEcCtD
Cabergoline—HTR1B—blood vessel—metabolic syndrome X	0.00338	0.0389	CbGeAlD
Cabergoline—Upset stomach—Metformin—metabolic syndrome X	0.00337	0.0732	CcSEcCtD
Cabergoline—HTR7—artery—metabolic syndrome X	0.00335	0.0385	CbGeAlD
Cabergoline—HTR1D—blood vessel—metabolic syndrome X	0.00327	0.0377	CbGeAlD
Cabergoline—HTR7—endothelium—metabolic syndrome X	0.00283	0.0326	CbGeAlD
Cabergoline—Pergolide—HTR2C—metabolic syndrome X	0.00272	0.535	CrCbGaD
Cabergoline—HTR7—blood vessel—metabolic syndrome X	0.00261	0.03	CbGeAlD
Cabergoline—Lisuride—HTR2C—metabolic syndrome X	0.00236	0.465	CrCbGaD
Cabergoline—HTR2A—artery—metabolic syndrome X	0.00209	0.024	CbGeAlD
Cabergoline—Lightheadedness—Metformin—metabolic syndrome X	0.00197	0.0429	CcSEcCtD
Cabergoline—ADRA1B—kidney—metabolic syndrome X	0.00195	0.0225	CbGeAlD
Cabergoline—HTR2A—endothelium—metabolic syndrome X	0.00176	0.0203	CbGeAlD
Cabergoline—Nasal congestion—Metformin—metabolic syndrome X	0.00176	0.0382	CcSEcCtD
Cabergoline—HTR2A—blood vessel—metabolic syndrome X	0.00163	0.0187	CbGeAlD
Cabergoline—HTR1B—cardiovascular system—metabolic syndrome X	0.00151	0.0174	CbGeAlD
Cabergoline—Liver function test abnormal—Metformin—metabolic syndrome X	0.00148	0.0321	CcSEcCtD
Cabergoline—Abdominal pain upper—Metformin—metabolic syndrome X	0.00146	0.0318	CcSEcCtD
Cabergoline—HTR1D—cardiovascular system—metabolic syndrome X	0.00146	0.0168	CbGeAlD
Cabergoline—HTR1D—kidney—metabolic syndrome X	0.00143	0.0164	CbGeAlD
Cabergoline—ADRB1—cardiovascular system—metabolic syndrome X	0.00142	0.0163	CbGeAlD
Cabergoline—Influenza—Metformin—metabolic syndrome X	0.00138	0.0301	CcSEcCtD
Cabergoline—HTR2B—cardiovascular system—metabolic syndrome X	0.00136	0.0156	CbGeAlD
Cabergoline—Sweating increased—Metformin—metabolic syndrome X	0.00135	0.0293	CcSEcCtD
Cabergoline—Abdominal discomfort—Metformin—metabolic syndrome X	0.00133	0.0288	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00129	0.028	CcSEcCtD
Cabergoline—ADRB1—adipose tissue—metabolic syndrome X	0.00125	0.0144	CbGeAlD
Cabergoline—HTR1A—cardiovascular system—metabolic syndrome X	0.00122	0.014	CbGeAlD
Cabergoline—HTR2B—adipose tissue—metabolic syndrome X	0.0012	0.0138	CbGeAlD
Cabergoline—HTR7—cardiovascular system—metabolic syndrome X	0.00116	0.0134	CbGeAlD
Cabergoline—HTR7—kidney—metabolic syndrome X	0.00114	0.0131	CbGeAlD
Cabergoline—ADRA1A—cardiovascular system—metabolic syndrome X	0.00112	0.0129	CbGeAlD
Cabergoline—Rhinitis—Metformin—metabolic syndrome X	0.00111	0.0241	CcSEcCtD
Cabergoline—Oedema peripheral—Metformin—metabolic syndrome X	0.00109	0.0237	CcSEcCtD
Cabergoline—ADRA2C—kidney—metabolic syndrome X	0.00105	0.012	CbGeAlD
Cabergoline—Cardiac disorder—Metformin—metabolic syndrome X	0.00103	0.0224	CcSEcCtD
Cabergoline—ADRA1A—adipose tissue—metabolic syndrome X	0.00099	0.0114	CbGeAlD
Cabergoline—Flatulence—Metformin—metabolic syndrome X	0.00095	0.0207	CcSEcCtD
Cabergoline—ADRA2C—adipose tissue—metabolic syndrome X	0.000943	0.0109	CbGeAlD
Cabergoline—Muscle spasms—Metformin—metabolic syndrome X	0.000927	0.0202	CcSEcCtD
Cabergoline—Ill-defined disorder—Metformin—metabolic syndrome X	0.000895	0.0195	CcSEcCtD
Cabergoline—Malaise—Metformin—metabolic syndrome X	0.00087	0.0189	CcSEcCtD
Cabergoline—Syncope—Metformin—metabolic syndrome X	0.000865	0.0188	CcSEcCtD
Cabergoline—Palpitations—Metformin—metabolic syndrome X	0.000852	0.0185	CcSEcCtD
Cabergoline—Loss of consciousness—Metformin—metabolic syndrome X	0.000848	0.0184	CcSEcCtD
Cabergoline—Hypertension—Metformin—metabolic syndrome X	0.000833	0.0181	CcSEcCtD
Cabergoline—Discomfort—Metformin—metabolic syndrome X	0.000811	0.0176	CcSEcCtD
Cabergoline—Oedema—Metformin—metabolic syndrome X	0.000787	0.0171	CcSEcCtD
Cabergoline—Shock—Metformin—metabolic syndrome X	0.000774	0.0168	CcSEcCtD
Cabergoline—Hyperhidrosis—Metformin—metabolic syndrome X	0.000761	0.0165	CcSEcCtD
Cabergoline—ADRA2A—adipose tissue—metabolic syndrome X	0.000752	0.00866	CbGeAlD
Cabergoline—Anorexia—Metformin—metabolic syndrome X	0.00075	0.0163	CcSEcCtD
Cabergoline—Hypotension—Metformin—metabolic syndrome X	0.000736	0.016	CcSEcCtD
Cabergoline—HTR2A—cardiovascular system—metabolic syndrome X	0.000726	0.00835	CbGeAlD
Cabergoline—HTR7—liver—metabolic syndrome X	0.00072	0.00828	CbGeAlD
Cabergoline—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000717	0.0156	CcSEcCtD
Cabergoline—HTR2A—kidney—metabolic syndrome X	0.00071	0.00817	CbGeAlD
Cabergoline—Paraesthesia—Metformin—metabolic syndrome X	0.000707	0.0154	CcSEcCtD
Cabergoline—Dyspnoea—Metformin—metabolic syndrome X	0.000702	0.0153	CcSEcCtD
Cabergoline—Somnolence—Metformin—metabolic syndrome X	0.0007	0.0152	CcSEcCtD
Cabergoline—ADRA1A—liver—metabolic syndrome X	0.000694	0.00799	CbGeAlD
Cabergoline—Dyspepsia—Metformin—metabolic syndrome X	0.000693	0.0151	CcSEcCtD
Cabergoline—Decreased appetite—Metformin—metabolic syndrome X	0.000684	0.0149	CcSEcCtD
Cabergoline—Fatigue—Metformin—metabolic syndrome X	0.000679	0.0148	CcSEcCtD
Cabergoline—Constipation—Metformin—metabolic syndrome X	0.000673	0.0146	CcSEcCtD
Cabergoline—ADRA2C—liver—metabolic syndrome X	0.000661	0.00761	CbGeAlD
Cabergoline—CYP3A4—kidney—metabolic syndrome X	0.000657	0.00756	CbGeAlD
Cabergoline—Feeling abnormal—Metformin—metabolic syndrome X	0.000649	0.0141	CcSEcCtD
Cabergoline—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000644	0.014	CcSEcCtD
Cabergoline—Abdominal pain—Metformin—metabolic syndrome X	0.000622	0.0135	CcSEcCtD
Cabergoline—Asthenia—Metformin—metabolic syndrome X	0.000565	0.0123	CcSEcCtD
Cabergoline—Pruritus—Metformin—metabolic syndrome X	0.000557	0.0121	CcSEcCtD
Cabergoline—Diarrhoea—Metformin—metabolic syndrome X	0.000539	0.0117	CcSEcCtD
Cabergoline—Dizziness—Metformin—metabolic syndrome X	0.000521	0.0113	CcSEcCtD
Cabergoline—Vomiting—Metformin—metabolic syndrome X	0.0005	0.0109	CcSEcCtD
Cabergoline—Rash—Metformin—metabolic syndrome X	0.000496	0.0108	CcSEcCtD
Cabergoline—Dermatitis—Metformin—metabolic syndrome X	0.000496	0.0108	CcSEcCtD
Cabergoline—Headache—Metformin—metabolic syndrome X	0.000493	0.0107	CcSEcCtD
Cabergoline—Nausea—Metformin—metabolic syndrome X	0.000468	0.0102	CcSEcCtD
Cabergoline—HTR2A—liver—metabolic syndrome X	0.000449	0.00516	CbGeAlD
Cabergoline—CYP3A4—liver—metabolic syndrome X	0.000415	0.00478	CbGeAlD
Cabergoline—CYP3A4—Metabolism—APOA5—metabolic syndrome X	1.37e-05	9.61e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—APOA1—metabolic syndrome X	1.37e-05	9.58e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—APOE—metabolic syndrome X	1.36e-05	9.56e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—LPL—metabolic syndrome X	1.36e-05	9.54e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IRS1—metabolic syndrome X	1.35e-05	9.49e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—APOA1—metabolic syndrome X	1.35e-05	9.45e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IRS1—metabolic syndrome X	1.34e-05	9.4e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—NOS3—metabolic syndrome X	1.34e-05	9.4e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.32e-05	9.28e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IRS1—metabolic syndrome X	1.32e-05	9.28e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—ALB—metabolic syndrome X	1.31e-05	9.22e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—SERPINE1—metabolic syndrome X	1.31e-05	9.16e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—SERPINE1—metabolic syndrome X	1.31e-05	9.16e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—AGT—metabolic syndrome X	1.3e-05	9.12e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—INS—metabolic syndrome X	1.3e-05	9.09e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IRS1—metabolic syndrome X	1.29e-05	9.08e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IRS1—metabolic syndrome X	1.29e-05	9.03e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—INS—metabolic syndrome X	1.28e-05	9e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—AGT—metabolic syndrome X	1.28e-05	8.97e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—CCL2—metabolic syndrome X	1.27e-05	8.94e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	1.27e-05	8.94e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—LEP—metabolic syndrome X	1.27e-05	8.93e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—APOE—metabolic syndrome X	1.27e-05	8.93e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—INS—metabolic syndrome X	1.27e-05	8.89e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—NOS3—metabolic syndrome X	1.26e-05	8.86e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—CCL2—metabolic syndrome X	1.26e-05	8.86e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—APOA1—metabolic syndrome X	1.26e-05	8.83e-05	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—TGFB1—metabolic syndrome X	1.26e-05	8.82e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—NOS3—metabolic syndrome X	1.26e-05	8.82e-05	CbGpPWpGaD
Cabergoline—HTR7—GPCR downstream signaling—AKT1—metabolic syndrome X	1.26e-05	8.81e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—APOE—metabolic syndrome X	1.25e-05	8.79e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—LEP—metabolic syndrome X	1.25e-05	8.79e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IGF1—metabolic syndrome X	1.25e-05	8.79e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—AGT—metabolic syndrome X	1.25e-05	8.78e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IRS1—metabolic syndrome X	1.25e-05	8.78e-05	CbGpPWpGaD
Cabergoline—HTR1D—GPCR downstream signaling—AKT1—metabolic syndrome X	1.25e-05	8.76e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CCL2—metabolic syndrome X	1.25e-05	8.75e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—NOS3—metabolic syndrome X	1.25e-05	8.75e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—NOS3—metabolic syndrome X	1.25e-05	8.75e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IGF1—metabolic syndrome X	1.24e-05	8.71e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—INS—metabolic syndrome X	1.24e-05	8.69e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—APOA1—metabolic syndrome X	1.24e-05	8.69e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—IL6—metabolic syndrome X	1.24e-05	8.68e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—INS—metabolic syndrome X	1.23e-05	8.65e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IRS1—metabolic syndrome X	1.23e-05	8.64e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—IL6—metabolic syndrome X	1.23e-05	8.62e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—LEP—metabolic syndrome X	1.23e-05	8.61e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—APOE—metabolic syndrome X	1.23e-05	8.61e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IGF1—metabolic syndrome X	1.23e-05	8.6e-05	CbGpPWpGaD
Cabergoline—HTR1B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.22e-05	8.57e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CCL2—metabolic syndrome X	1.22e-05	8.55e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CCL2—metabolic syndrome X	1.21e-05	8.51e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—APOA1—metabolic syndrome X	1.21e-05	8.51e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—IL6—metabolic syndrome X	1.2e-05	8.44e-05	CbGpPWpGaD
Cabergoline—DRD4—GPCR downstream signaling—AKT1—metabolic syndrome X	1.2e-05	8.44e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—INS—metabolic syndrome X	1.2e-05	8.41e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IGF1—metabolic syndrome X	1.2e-05	8.41e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IGF1—metabolic syndrome X	1.19e-05	8.36e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.19e-05	8.35e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—PPARG—metabolic syndrome X	1.19e-05	8.33e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—IL6—metabolic syndrome X	1.18e-05	8.31e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—INS—metabolic syndrome X	1.18e-05	8.28e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CCL2—metabolic syndrome X	1.18e-05	8.28e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.18e-05	8.27e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—INS—metabolic syndrome X	1.16e-05	8.17e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.16e-05	8.17e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	1.16e-05	8.16e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CCL2—metabolic syndrome X	1.16e-05	8.14e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IGF1—metabolic syndrome X	1.16e-05	8.14e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	1.16e-05	8.12e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—PTGS2—metabolic syndrome X	1.15e-05	8.07e-05	CbGpPWpGaD
Cabergoline—HTR2B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.15e-05	8.05e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	1.14e-05	8.02e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IGF1—metabolic syndrome X	1.14e-05	8.01e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—AKT1—metabolic syndrome X	1.14e-05	8e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	1.14e-05	8e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	1.14e-05	8e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.14e-05	7.98e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IRS1—metabolic syndrome X	1.14e-05	7.97e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—NOS3—metabolic syndrome X	1.14e-05	7.97e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—LIPC—metabolic syndrome X	1.14e-05	7.97e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GCK—metabolic syndrome X	1.14e-05	7.97e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—AKT1—metabolic syndrome X	1.13e-05	7.95e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.13e-05	7.94e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—IL6—metabolic syndrome X	1.13e-05	7.93e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—APOC3—metabolic syndrome X	1.13e-05	7.92e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	1.13e-05	7.91e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—NOS3—metabolic syndrome X	1.13e-05	7.9e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	1.12e-05	7.84e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—NOS3—metabolic syndrome X	1.11e-05	7.8e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—AKT1—metabolic syndrome X	1.11e-05	7.79e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.1e-05	7.73e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CETP—metabolic syndrome X	1.1e-05	7.69e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	1.09e-05	7.68e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—AKT1—metabolic syndrome X	1.09e-05	7.66e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—INS—metabolic syndrome X	1.09e-05	7.63e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	1.09e-05	7.62e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.08e-05	7.6e-05	CbGpPWpGaD
Cabergoline—DRD1—GPCR downstream signaling—AKT1—metabolic syndrome X	1.08e-05	7.6e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	1.08e-05	7.58e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—INS—metabolic syndrome X	1.07e-05	7.51e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	1.07e-05	7.51e-05	CbGpPWpGaD
Cabergoline—DRD3—GPCR downstream signaling—AKT1—metabolic syndrome X	1.07e-05	7.49e-05	CbGpPWpGaD
Cabergoline—ADRA1D—GPCR downstream signaling—AKT1—metabolic syndrome X	1.07e-05	7.49e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—ALB—metabolic syndrome X	1.07e-05	7.49e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—IL6—metabolic syndrome X	1.07e-05	7.48e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	1.05e-05	7.39e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	1.05e-05	7.38e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—IL6—metabolic syndrome X	1.05e-05	7.38e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—IL6—metabolic syndrome X	1.05e-05	7.38e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—NOS3—metabolic syndrome X	1.05e-05	7.38e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	1.05e-05	7.36e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	1.05e-05	7.35e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—AKT1—metabolic syndrome X	1.04e-05	7.31e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	1.04e-05	7.26e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—NOS3—metabolic syndrome X	1.03e-05	7.26e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	1.03e-05	7.23e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—NOS3—metabolic syndrome X	1.02e-05	7.17e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	1.02e-05	7.14e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	1.02e-05	7.13e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	1.01e-05	7.11e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	9.99e-06	7.01e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	9.91e-06	6.95e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GOT2—metabolic syndrome X	9.91e-06	6.95e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—AKT1—metabolic syndrome X	9.83e-06	6.9e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	9.83e-06	6.9e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	9.74e-06	6.83e-05	CbGpPWpGaD
Cabergoline—ADRB1—GPCR downstream signaling—AKT1—metabolic syndrome X	9.73e-06	6.83e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—AKT1—metabolic syndrome X	9.7e-06	6.81e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—AKT1—metabolic syndrome X	9.7e-06	6.81e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—TGFB1—metabolic syndrome X	9.69e-06	6.8e-05	CbGpPWpGaD
Cabergoline—ADRA2B—GPCR downstream signaling—AKT1—metabolic syndrome X	9.64e-06	6.77e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—TGFB1—metabolic syndrome X	9.63e-06	6.76e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	9.63e-06	6.75e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—IL6—metabolic syndrome X	9.58e-06	6.72e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	9.58e-06	6.72e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	9.54e-06	6.69e-05	CbGpPWpGaD
Cabergoline—ADRB2—GPCR downstream signaling—AKT1—metabolic syndrome X	9.52e-06	6.68e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—IL6—metabolic syndrome X	9.49e-06	6.66e-05	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—IL6—metabolic syndrome X	9.47e-06	6.65e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—TGFB1—metabolic syndrome X	9.43e-06	6.62e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	9.42e-06	6.61e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	9.39e-06	6.59e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—IL6—metabolic syndrome X	9.37e-06	6.58e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	9.34e-06	6.55e-05	CbGpPWpGaD
Cabergoline—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	9.31e-06	6.53e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—TGFB1—metabolic syndrome X	9.28e-06	6.51e-05	CbGpPWpGaD
Cabergoline—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	9.26e-06	6.5e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	9.19e-06	6.45e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	9.16e-06	6.43e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	9.12e-06	6.4e-05	CbGpPWpGaD
Cabergoline—ADRA2C—GPCR downstream signaling—AKT1—metabolic syndrome X	9.01e-06	6.32e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	8.94e-06	6.28e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—IL6—metabolic syndrome X	8.87e-06	6.22e-05	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR downstream signaling—AKT1—metabolic syndrome X	8.87e-06	6.22e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—TGFB1—metabolic syndrome X	8.86e-06	6.22e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—AKT1—metabolic syndrome X	8.84e-06	6.2e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	8.83e-06	6.19e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	8.83e-06	6.19e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—AKT1—metabolic syndrome X	8.76e-06	6.14e-05	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—AKT1—metabolic syndrome X	8.74e-06	6.13e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—IL6—metabolic syndrome X	8.73e-06	6.12e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—AKT1—metabolic syndrome X	8.65e-06	6.07e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GOT1—metabolic syndrome X	8.55e-06	6e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GGT1—metabolic syndrome X	8.55e-06	6e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	8.54e-06	5.99e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	8.45e-06	5.93e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	8.41e-06	5.9e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—TGFB1—metabolic syndrome X	8.35e-06	5.86e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—TGFB1—metabolic syndrome X	8.24e-06	5.78e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—TGFB1—metabolic syndrome X	8.24e-06	5.78e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—AKT1—metabolic syndrome X	8.18e-06	5.74e-05	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	8.17e-06	5.73e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—AKT1—metabolic syndrome X	8.05e-06	5.65e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	8.05e-06	5.65e-05	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.04e-06	5.64e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	7.92e-06	5.55e-05	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.87e-06	5.53e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	7.75e-06	5.44e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—TGFB1—metabolic syndrome X	7.51e-06	5.27e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—TGFB1—metabolic syndrome X	7.44e-06	5.22e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	7.42e-06	5.21e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—TGFB1—metabolic syndrome X	7.35e-06	5.15e-05	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.32e-06	5.13e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—IL6—metabolic syndrome X	7.3e-06	5.13e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	7.3e-06	5.12e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—IL6—metabolic syndrome X	7.26e-06	5.09e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—APOB—metabolic syndrome X	7.26e-06	5.09e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	7.2e-06	5.05e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	7.18e-06	5.04e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	7.15e-06	5.02e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	7.15e-06	5.01e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—IL6—metabolic syndrome X	7.11e-06	4.99e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	7.06e-06	4.95e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—IL6—metabolic syndrome X	6.99e-06	4.91e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—TGFB1—metabolic syndrome X	6.95e-06	4.88e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—LPL—metabolic syndrome X	6.93e-06	4.86e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—TGFB1—metabolic syndrome X	6.84e-06	4.8e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—AKT1—metabolic syndrome X	6.74e-06	4.73e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—AKT1—metabolic syndrome X	6.69e-06	4.7e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—IL6—metabolic syndrome X	6.68e-06	4.68e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	6.64e-06	4.66e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—CD36—metabolic syndrome X	6.58e-06	4.62e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—AKT1—metabolic syndrome X	6.56e-06	4.6e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—AKT1—metabolic syndrome X	6.45e-06	4.53e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	6.31e-06	4.43e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IL6—metabolic syndrome X	6.29e-06	4.42e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IL6—metabolic syndrome X	6.21e-06	4.36e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IL6—metabolic syndrome X	6.21e-06	4.36e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	6.21e-06	4.35e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—AKT1—metabolic syndrome X	6.16e-06	4.32e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PPARA—metabolic syndrome X	6.12e-06	4.29e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	6.08e-06	4.26e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—AGT—metabolic syndrome X	5.93e-06	4.16e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—AKT1—metabolic syndrome X	5.81e-06	4.07e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—APOE—metabolic syndrome X	5.81e-06	4.07e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—AKT1—metabolic syndrome X	5.78e-06	4.05e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—APOA1—metabolic syndrome X	5.74e-06	4.03e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—AKT1—metabolic syndrome X	5.73e-06	4.02e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—AKT1—metabolic syndrome X	5.73e-06	4.02e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IL6—metabolic syndrome X	5.66e-06	3.97e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	5.65e-06	3.96e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IL6—metabolic syndrome X	5.61e-06	3.93e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IL6—metabolic syndrome X	5.54e-06	3.88e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	5.41e-06	3.8e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	5.39e-06	3.78e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IL6—metabolic syndrome X	5.24e-06	3.68e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—AKT1—metabolic syndrome X	5.22e-06	3.66e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—AKT1—metabolic syndrome X	5.17e-06	3.63e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IL6—metabolic syndrome X	5.16e-06	3.62e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—AKT1—metabolic syndrome X	5.11e-06	3.58e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PPARG—metabolic syndrome X	5.06e-06	3.55e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	4.99e-06	3.5e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	4.97e-06	3.49e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—INS—metabolic syndrome X	4.96e-06	3.48e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—AKT1—metabolic syndrome X	4.83e-06	3.39e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—AKT1—metabolic syndrome X	4.76e-06	3.34e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IL6—metabolic syndrome X	4.75e-06	3.33e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—AKT1—metabolic syndrome X	4.69e-06	3.29e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	4.68e-06	3.28e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	4.58e-06	3.21e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ALB—metabolic syndrome X	4.55e-06	3.19e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	4.38e-06	3.08e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—NOS3—metabolic syndrome X	4.35e-06	3.05e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	4.31e-06	3.03e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	4.25e-06	2.99e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	4.22e-06	2.96e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	3.98e-06	2.79e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	3.92e-06	2.75e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—AKT1—metabolic syndrome X	2e-06	1.4e-05	CbGpPWpGaD
